Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Sodium hyaluronate adverse reaction |
Causative agent (attribute) |
False |
Sodium hyaluronate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sodium hyaluronate allergy |
Causative agent (attribute) |
False |
Sodium hyaluronate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium hyaluronate 40mg/50mL bladder instillation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium hyaluronate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium hyaluronate [anti-rheumatic] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium hyaluronate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium hyaluronate 20mg/2mL intra-articular injection prefilled syringe (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium hyaluronate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium hyaluronate 25mg/2.5mL intra-articular injection prefilled syringe (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium hyaluronate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium hyaluronate 30mg/2mL intra-articular injection prefilled syringe (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium hyaluronate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium hyaluronate10mg/mL intra-ocular injection prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium hyaluronate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium hyaluronate 14mg/mL injection solution prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium hyaluronate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium hyaluronate 15mg/mL injection solution prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium hyaluronate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium hyaluronate+sodium chondroitin sulfate 30mg/40mg/1mL intra-ocular injection prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium hyaluronate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium hyaluronate 23mg/mL intra-ocular injection prefilled syringe (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium hyaluronate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing sodium hyaluronate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium hyaluronate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium hyaluronate 10mg/mL injection solution 0.55mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium hyaluronate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium hyaluronate 10mg/mL injection solution 0.85mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium hyaluronate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium hyaluronate 10mg/mL injection solution 1mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium hyaluronate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium hyaluronate 10mg/mL intra-ocular injection 0.55mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium hyaluronate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium hyaluronate10mg/mL intra-ocular injection 0.85mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium hyaluronate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium hyaluronate 10mg/mL intra-ocular injection 1mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium hyaluronate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium hyaluronate 14mg/mL injection solution 1mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium hyaluronate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium hyaluronate 15mg/mL injection solution 1mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium hyaluronate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium hyaluronate 23mg/mL injection solution 0.6mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium hyaluronate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Povidone+sodium hyaluronate oral gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium hyaluronate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium hyaluronate 60mg/3mL intra-articular injection prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium hyaluronate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium hyaluronate 1.2% injection solution 0.5mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium hyaluronate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium hyaluronate 1.2% injection solution 0.8mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium hyaluronate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium hyaluronate 3% injection solution 0.6mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium hyaluronate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium hyaluronate 10mg/mL injection solution 0.4mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium hyaluronate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium hyaluronate 1.6% injection solution 0.5mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium hyaluronate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium hyaluronate 1.6% injection solution 0.8mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium hyaluronate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium hyaluronate 10mg/mL injection solution 0.5mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium hyaluronate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium hyaluronate 2% injection solution 1mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium hyaluronate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium hyaluronate 14mg/mL injection solution 0.55mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium hyaluronate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium hyaluronate 14mg/mL injection solution 0.85mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium hyaluronate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing enoxolone and hyaluronate sodium and povidone |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium hyaluronate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glycyrrhetinic acid + hyaluronate sodium + polyvinyl pyrrolidone powder for oral gel 15mL packet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium hyaluronate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium hyaluronate 20mg/2mL intra-articular injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium hyaluronate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium hyaluronate 10micrograms/mL preservative-free eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium hyaluronate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing hyaluronate sodium in oral dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium hyaluronate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Intraarticular hyaluronate sodium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium hyaluronate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ophthalmic hyaluronate sodium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium hyaluronate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing hyaluronate sodium in parenteral dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium hyaluronate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium hyaluronate allergy |
Causative agent (attribute) |
False |
Sodium hyaluronate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sodium hyaluronate 10micrograms/mL conventional release eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium hyaluronate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely sodium hyaluronate 8.5 milligram/0.85 milliliter conventional release solution for intraocular injection syringe (clinical drug) |
Has basis of strength substance (attribute) |
False |
Sodium hyaluronate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely sodium hyaluronate 8.5 milligram/0.85 milliliter conventional release solution for intraocular injection syringe (clinical drug) |
Has precise active ingredient |
False |
Sodium hyaluronate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely sodium hyaluronate 5.5 milligram/0.55 milliliter conventional release solution for intraocular injection syringe (clinical drug) |
Has precise active ingredient |
False |
Sodium hyaluronate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely sodium hyaluronate 5.5 milligram/0.55 milliliter conventional release solution for intraocular injection syringe (clinical drug) |
Has basis of strength substance (attribute) |
False |
Sodium hyaluronate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely sodium hyaluronate 10 milligram/1 milliliter conventional release solution for intraocular injection (clinical drug) |
Has basis of strength substance (attribute) |
False |
Sodium hyaluronate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely sodium hyaluronate 10 milligram/1 milliliter conventional release solution for intraocular injection (clinical drug) |
Has precise active ingredient |
False |
Sodium hyaluronate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely sodium hyaluronate 23 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Sodium hyaluronate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely sodium hyaluronate 23 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has precise active ingredient |
True |
Sodium hyaluronate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely sodium hyaluronate 20 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Sodium hyaluronate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely sodium hyaluronate 20 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Sodium hyaluronate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely sodium hyaluronate 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has precise active ingredient |
True |
Sodium hyaluronate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely sodium hyaluronate 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Sodium hyaluronate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |